Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-105443
Filing Date
2024-10-02
Accepted
2024-10-02 16:12:07
Documents
1
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2425372-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2425372-1_4seq1.xml 4 10119
  Complete submission text file 0001104659-24-105443.txt   11621
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Issuer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 26 PATRIOT PLACE, SUITE 301 FOXBORO MA 02035
Business Address
Mosca Alison (Reporting) CIK: 0001835537 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39834 | Film No.: 241347440